share_log

CVS Health | 8-K: Current report

CVS Health | 8-K: Current report

西維斯健康 | 8-K:重大事件
美股SEC公告 ·  12/09 20:11

牛牛AI助理已提取核心訊息

CVS Health announced the results of its cash tender offer for any and all of its 4.100% Senior Notes due 2025. As of December 6, 2024, $225,979,000 principal amount was validly tendered, with an additional $5,000 tendered under guaranteed delivery procedures. The settlement date is expected to be December 11, 2024.CVS Health plans to accept all validly tendered notes for purchase. The tender offer will be funded using proceeds from the issuance of new junior subordinated notes. The company also announced a concurrent Maximum Tender Offer for other notes, with a maximum purchase price of $2 billion less the amount paid for the 2025 Notes.The tender offers are part of CVS Health's ongoing efforts to manage its debt profile. As of September 30, 2024, the company operated over 9,000 retail locations, 900+ walk-in clinics, and served approximately 90 million pharmacy benefits members, showcasing its significant presence in the healthcare sector.
CVS Health announced the results of its cash tender offer for any and all of its 4.100% Senior Notes due 2025. As of December 6, 2024, $225,979,000 principal amount was validly tendered, with an additional $5,000 tendered under guaranteed delivery procedures. The settlement date is expected to be December 11, 2024.CVS Health plans to accept all validly tendered notes for purchase. The tender offer will be funded using proceeds from the issuance of new junior subordinated notes. The company also announced a concurrent Maximum Tender Offer for other notes, with a maximum purchase price of $2 billion less the amount paid for the 2025 Notes.The tender offers are part of CVS Health's ongoing efforts to manage its debt profile. As of September 30, 2024, the company operated over 9,000 retail locations, 900+ walk-in clinics, and served approximately 90 million pharmacy benefits members, showcasing its significant presence in the healthcare sector.
西維斯健康宣佈了其對於任何到期爲2025年的4.100%高級票據的現金要約結果。截至2024年12月6日,有效認購金額爲225,979,000美元,另有5,000美元在保證交付程序下認購。結算日期預計爲2024年12月11日。西維斯健康計劃接受所有有效認購的票據進行購買。該要約將通過發行新的一般次級票據的收益進行資金支持。該公司還宣佈了與之並行的其他票據的最高要約,最高購買價格爲20億減去爲2025年票據支付的金額。這些要約是西維斯健康持續管理其債務結構的一部分。截至2024年9月30日,該公司運營超過9,000個零售店,900多家步入式診所,並服務於大約9000萬藥房福利成員,展示了其在醫療保健板塊中的顯著存在。
西維斯健康宣佈了其對於任何到期爲2025年的4.100%高級票據的現金要約結果。截至2024年12月6日,有效認購金額爲225,979,000美元,另有5,000美元在保證交付程序下認購。結算日期預計爲2024年12月11日。西維斯健康計劃接受所有有效認購的票據進行購買。該要約將通過發行新的一般次級票據的收益進行資金支持。該公司還宣佈了與之並行的其他票據的最高要約,最高購買價格爲20億減去爲2025年票據支付的金額。這些要約是西維斯健康持續管理其債務結構的一部分。截至2024年9月30日,該公司運營超過9,000個零售店,900多家步入式診所,並服務於大約9000萬藥房福利成員,展示了其在醫療保健板塊中的顯著存在。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。